Search all trials

Find therapies in clinical trials near you – page 36

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed High-Risk Multiple Myeloma Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Granulomatosis with polyangiitis+1

Not recruiting

Investigational

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Graft versus host disease+1

Not recruiting

Registered drugNo placebo

Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Graves' disease

Not recruiting

InvestigationalNo placebo

Study on the Effects of Batoclimab for Patients with Graves' Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Batoclimab

Contact Research Centre

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Not recruiting

Registered drugNo placebo

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Buparlisib

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Danicopan

Contact Research Centre

Rectal cancer

Not recruiting

Registered drugNo placebo

Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Essential thrombocythaemia

Not recruiting

Registered drug

Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bomedemstat

Contact Research Centre

Leukaemia+1

Not recruiting

InvestigationalNo placebo

Study on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Allogeneic Cd4+ And Cd25+ T Lymphocytes Ex Vivo Incubated With Gp120

Contact Research Centre

Metastatic neoplasm+1

Not recruiting

Registered drugNo placebo

Study on Treating Advanced Cancers with BRAF Mutations Using Sorafenib and Trametinib for Patients with Impaired Kinase Activity

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Sorafenib

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis

Registered drug

Germany

Participants:0–17 years
Substances:Tralokinumab

Contact Research Centre

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting

Registered drugNo placebo

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bleomycin Sulfate

Contact Research Centre

Find therapies in clinical trials near you – page 36

601 trials match your criteria

Plasma cell myeloma

Study on Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed High-Risk Multiple Myeloma Patients

Granulomatosis with polyangiitis+1

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Graft versus host disease+1

Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Graves' disease

Study on the Effects of Batoclimab for Patients with Graves' Disease

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Chronic spontaneous urticaria

Study on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines

Rectal cancer

Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Essential thrombocythaemia

Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Leukaemia+1

Study on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease

Metastatic neoplasm+1

Study on Treating Advanced Cancers with BRAF Mutations Using Sorafenib and Trametinib for Patients with Impaired Kinase Activity

Dermatitis atopic

Study on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.